| Cash Flow | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net income | -50,180 | 96,799 | 16,144 | 50,806 |
| Depreciation and amortization | -4,759 | 5,003 | 5,248 | 5,092 |
| Gain on warrant liability | NaN | NaN | 0 | 0 |
| Loss on warrant liability | NaN | 0 | NaN | NaN |
| Impairment of assets | NaN | 0 | 0 | NaN |
| Impairment of goodwill | NaN | 0 | 0 | NaN |
| Derecognition of goodwill | NaN | 0 | 0 | NaN |
| Stock-based compensation expense | -95,879 | 13,217 | 78,747 | 27,642 |
| Changes to deferred taxes | -26,374 | 27,807 | -2,365 | -2,500 |
| Debt accretion expense | -470 | 252 | 251 | 253 |
| (increase)/decrease in accounts receivable-Nonrelated Party | -72,207 | 38,192 | 54,135 | 62,633 |
| (increase)/decrease in accounts receivable-Related Party | -2,734 | 1,616 | 1,479 | 656 |
| (increase)/decrease in inventories | 1,773 | 883 | -843 | 268 |
| (increase)/decrease in income tax receivable | NaN | 12,097 | NaN | NaN |
| (increase)/decrease in prepaid expenses and other current assets | -11,216 | -2,264 | 7,262 | 1,378 |
| (increase)/decrease in operating right-of-use assets | 289 | 397 | -285 | 406 |
| Increase/(decrease) in accounts payable-Nonrelated Party | -26,126 | 17,303 | 9,112 | 10,222 |
| Increase/(decrease) in accounts payable-Related Party | -1,126 | 2,107 | -165 | 1,334 |
| Increase/(decrease) in operating lease liabilities | -461 | -358 | 439 | -245 |
| Increase/(decrease) in accrued arbitration expenses | 5,420 | 4,472 | -16,982 | -4,061 |
| Increase/(decrease) in accrued income tax expense | 60,858 | -8,364 | -37,767 | 19,598 |
| Increase/(decrease) in accrued expenses and other current liabilities | 1,914 | 347 | 2,949 | -769 |
| Net cash provided by operating activities | -51,253 | 99,514 | 27,257 | 50,965 |
| Acquisitions of property and equipment | 148 | 302 | 751 | 64 |
| Proceeds from restricted short-term investment | NaN | 0 | 2,941 | NaN |
| Cash related to sale of business | NaN | 0 | 0 | NaN |
| Cash related to asset acquisition | NaN | 0 | 1,994 | NaN |
| Net cash used in investing activities | -1,095 | -302 | 196 | -64 |
| Proceeds from lines of credit | -1,179 | 437 | 742 | 3,864 |
| Proceeds from long-term debt | NaN | NaN | NaN | 157 |
| Proceeds from notes payable | -273 | 15 | 258 | NaN |
| Repayments of lines of credit | -2,407 | 2,992 | 9 | 292 |
| Repayments of long-term debt | NaN | NaN | NaN | 1,810 |
| Repayments of notes payable | -6,765 | 2,622 | 5,697 | NaN |
| Repayments of finance leases | -1,084 | 1,411 | 1,226 | 1,367 |
| Proceeds from common stock issuance, net issuance costs | NaN | 0 | 0 | 0 |
| Proceeds from exercise of warrants | NaN | 0 | NaN | NaN |
| Cash related to stock repurchases and retirements | 31,730 | NaN | NaN | NaN |
| Members' contributions | 923 | 74 | 242 | NaN |
| Members' distributions | -19,453 | 23,398 | 11,412 | 7,364 |
| Net cash used in financing activities | -4,203 | -29,897 | -15,449 | -6,812 |
| Net change in cash, cash equivalents, and restricted cash | -56,551 | 69,315 | 12,004 | 44,089 |
| Cash and cash equivalents at beginning of period | NaN | 96,733 | 84,729 | 40,640 |
| Cash and cash equivalents at end of period | NaN | 166,048 | 96,733 | 84,729 |
Nutex Health Inc. (NUTX)
Nutex Health Inc. (NUTX)